These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 11159552)

  • 1. Mutations in the NMMHC-A gene cause autosomal dominant macrothrombocytopenia with leukocyte inclusions (May-Hegglin anomaly/Sebastian syndrome).
    Kunishima S; Kojima T; Matsushita T; Tanaka T; Tsurusawa M; Furukawa Y; Nakamura Y; Okamura T; Amemiya N; Nakayama T; Kamiya T; Saito H
    Blood; 2001 Feb; 97(4):1147-9. PubMed ID: 11159552
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of six novel MYH9 mutations and genotype-phenotype relationships in autosomal dominant macrothrombocytopenia with leukocyte inclusions.
    Kunishima S; Matsushita T; Kojima T; Amemiya N; Choi YM; Hosaka N; Inoue M; Jung Y; Mamiya S; Matsumoto K; Miyajima Y; Zhang G; Ruan C; Saito K; Song KS; Yoon HJ; Kamiya T; Saito H
    J Hum Genet; 2001; 46(12):722-9. PubMed ID: 11776386
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutation of MYH9, encoding non-muscle myosin heavy chain A, in May-Hegglin anomaly.
    Kelley MJ; Jawien W; Ortel TL; Korczak JF
    Nat Genet; 2000 Sep; 26(1):106-8. PubMed ID: 10973260
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Asp1424Asn MYH9 mutation results in an unstable protein responsible for the phenotypes in May-Hegglin anomaly/Fechtner syndrome.
    Deutsch S; Rideau A; Bochaton-Piallat ML; Merla G; Geinoz A; Gabbiani G; Schwede T; Matthes T; Antonarakis SE; Beris P
    Blood; 2003 Jul; 102(2):529-34. PubMed ID: 12649151
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [May-Hegglin anomaly--from genome research to clinical laboratory].
    Kunishima S
    Rinsho Byori; 2003 Sep; 51(9):898-904. PubMed ID: 14560660
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutations in MYH9 result in the May-Hegglin anomaly, and Fechtner and Sebastian syndromes. The May-Heggllin/Fechtner Syndrome Consortium.
    Seri M; Cusano R; Gangarossa S; Caridi G; Bordo D; Lo Nigro C; Ghiggeri GM; Ravazzolo R; Savino M; Del Vecchio M; d'Apolito M; Iolascon A; Zelante LL; Savoia A; Balduini CL; Noris P; Magrini U; Belletti S; Heath KE; Babcock M; Glucksman MJ; Aliprandis E; Bizzaro N; Desnick RJ; Martignetti JA
    Nat Genet; 2000 Sep; 26(1):103-5. PubMed ID: 10973259
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A notable case report of May-Hegglin anomaly with immune complex-related nephropathy: a genetic and histological analysis.
    Ohtsuka Y; Kanaji T; Nishi M; Sakai N; Sato T; Aoki S; Wakayama K; Nakazato S; Hisano S; Sado Y; Kawachi H; Izuhara K; Hamasaki Y
    Clin Nephrol; 2011 Mar; 75(3):255-62. PubMed ID: 21329637
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Usefulness of immunofluorescence analysis of neutrophil nonmuscle myosin heavy chain-A for diagnosing in two sisters with May-Hegglin anomaly].
    Kimura N; Matsumoto M; Matsumoto K; Asai N; Kunishima S
    Rinsho Ketsueki; 2008 Dec; 49(12):1614-8. PubMed ID: 19110523
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nonmuscle myosin heavy chain IIA mutations define a spectrum of autosomal dominant macrothrombocytopenias: May-Hegglin anomaly and Fechtner, Sebastian, Epstein, and Alport-like syndromes.
    Heath KE; Campos-Barros A; Toren A; Rozenfeld-Granot G; Carlsson LE; Savige J; Denison JC; Gregory MC; White JG; Barker DF; Greinacher A; Epstein CJ; Glucksman MJ; Martignetti JA
    Am J Hum Genet; 2001 Nov; 69(5):1033-45. PubMed ID: 11590545
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Autosomal dominant macrothrombocytopenia with leukocyte inclusion bodies and MYH9 disorders].
    Kunishima S
    Rinsho Byori; 2009 Apr; 57(4):365-70. PubMed ID: 19489439
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MYH9-related disease: May-Hegglin anomaly, Sebastian syndrome, Fechtner syndrome, and Epstein syndrome are not distinct entities but represent a variable expression of a single illness.
    Seri M; Pecci A; Di Bari F; Cusano R; Savino M; Panza E; Nigro A; Noris P; Gangarossa S; Rocca B; Gresele P; Bizzaro N; Malatesta P; Koivisto PA; Longo I; Musso R; Pecoraro C; Iolascon A; Magrini U; Rodriguez Soriano J; Renieri A; Ghiggeri GM; Ravazzolo R; Balduini CL; Savoia A
    Medicine (Baltimore); 2003 May; 82(3):203-15. PubMed ID: 12792306
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autosomal dominant macrothrombocytopenia with leukocyte inclusions (May-Hegglin anomaly) is linked to chromosome 22q12-13.
    Kelley MJ; Jawien W; Lin A; Hoffmeister K; Pugh EW; Doheny KF; Korczak JF
    Hum Genet; 2000 May; 106(5):557-64. PubMed ID: 10914687
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Immunofluorescence localization of inclusion and identification of nonmuscle myosin heavy chain IIA in neutrophils of May-Hegglin anomaly patients].
    Yi Y; Zhang GS
    Zhonghua Yi Xue Za Zhi; 2003 Aug; 83(15):1313-6. PubMed ID: 12930685
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epstein syndrome: another renal disorder with mutations in the nonmuscle myosin heavy chain 9 gene.
    Seri M; Savino M; Bordo D; Cusano R; Rocca B; Meloni I; Di Bari F; Koivisto PA; Bolognesi M; Ghiggeri GM; Landolfi R; Balduini CL; Zelante L; Ravazzolo R; Renieri A; Savoia A
    Hum Genet; 2002 Feb; 110(2):182-6. PubMed ID: 11935325
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cloning of the murine non-muscle myosin heavy chain IIA gene ortholog of human MYH9 responsible for May-Hegglin, Sebastian, Fechtner, and Epstein syndromes.
    D'Apolito M; Guarnieri V; Boncristiano M; Zelante L; Savoia A
    Gene; 2002 Mar; 286(2):215-22. PubMed ID: 11943476
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunocytochemistry for the heavy chain of the non-muscle myosin IIA as a diagnostic tool for MYH9-related disorders.
    Pecci A; Noris P; Invernizzi R; Savoia A; Seri M; Ghiggeri GM; Sartore S; Gangarossa S; Bizzaro N; Balduini CL
    Br J Haematol; 2002 Apr; 117(1):164-7. PubMed ID: 11918549
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Historical hematology: May-Hegglin anomaly.
    Saito H; Kunishima S
    Am J Hematol; 2008 Apr; 83(4):304-6. PubMed ID: 17975807
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MYH9 related platelet disorders - often unknown and misdiagnosed.
    Althaus K; Najm J; Greinacher A
    Klin Padiatr; 2011 May; 223(3):120-5. PubMed ID: 21567368
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mapping of a gene for May-Hegglin anomaly to chromosome 22q.
    Kunishima S; Kojima T; Tanaka T; Kamiya T; Ozawa K; Nakamura Y; Saito H
    Hum Genet; 1999 Nov; 105(5):379-83. PubMed ID: 10598801
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of clinical manifestations, mutant gene and encoded protein in two Chinese MYH9-related disease families.
    Yi Y; Sen Zhang G; Xu M; San Ling Z; Ru Shao X; Zeng Li J; Ma J
    Clin Chim Acta; 2006 Nov; 373(1-2):49-54. PubMed ID: 16806139
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.